AKT1 and acute lymphoblastic leukemia: Therapeutic targeting of the IL-7Ra signaling pathways including the Akt inhibitors were also recommended in ALL treatment33, but the cellular mechanisms of Akt signaling pathway underlying GC resistance were not fully elucidated in this study.